Article Text

Download PDFPDF
Systemic energy homeostasis in Huntington's disease patients
  1. N Ahmad Aziz1,
  2. Hanno Pijl2,
  3. Marijke Frölich3,
  4. Marieke Snel4,
  5. Trea C M Streefland2,
  6. Ferdinand Roelfsema2,
  7. Raymund A C Roos1
  1. 1Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands
  2. 2Endocrinology and Metabolic Diseases, Leiden University Medical Centre, Leiden, The Netherlands
  3. 3Clinical Chemistry, Leiden University Medical Centre, Leiden, The Netherlands
  4. 4General Internal Medicine, Leiden University Medical Centre, Leiden, The Netherlands
  1. Correspondence to Dr N A Aziz, Department of Neurology, Leiden University Medical Centre, K-05-Q 110, PO Box 9600, Albinusdreef 2, Leiden 2300 RC, The Netherlands; n.a.aziz{at}


Background Huntington's disease (HD) is a hereditary neurodegenerative disorder caused by an increased number of CAG repeats in the HTT gene. Apart from neurological impairment, the disease is also accompanied by progressive weight loss, abnormalities in fat and glucose homeostasis and a higher prevalence of diabetes mellitus, the causes of which are unknown. Therefore, a detailed analysis of systemic energy homeostasis in HD patients in relation to disease characteristics was performed.

Methods Indirect calorimetry combined with a hyperinsulinaemic–euglycaemic clamp with stable isotopes ([6,6-2H2]-glucose and [2H5]- glycerol) was performed to assess energy expenditure and glucose and fat metabolism in nine early stage, medication free HD patients and nine age, sex and body mass index matched controls.

Results Compared with controls, fasting energy expenditure was higher in HD patients (1616±72 vs 1883±93 kcal/24 h, p=0.037) and increased even further after insulin stimulation (1667±87 vs 2068±122 kcal/24 h, p=0.016). During both basal and hyperinsulinaemic conditions, glucose and glycerol disposal rates, endogenous glucose production and hepatic insulin sensitivity were similar between HD patients and controls. In HD patients, energy expenditure increased with disease duration but not with a greater degree of motor or functional impairment. Moreover, a higher mutant CAG repeat size was associated with lower insulin sensitivity (r=−0.84, p=0.018).

Conclusion These findings suggest sympathetic hyperactivity as an underlying mechanism of increased energy expenditure in HD, as well as peripheral polyglutamine length dependent interference of mutant huntingtin with insulin signalling that may become clinically relevant in carriers of mutations with large CAG repeat sizes.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding This work was supported by the Netherlands Organisation for Scientific Research (grant No 017.003.098 to NAA).

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the ethics committee of the Leiden University Medical Centre.

  • Provenance and peer review Not commissioned; externally peer reviewed.